News RSS Bioethics News.

08/11/2017

CRISPR fixes disease gene in viable human embryos

External Link - Source: Nature

An international team of researchers has used CRISPR–Cas9 gene editing — a technique that allows scientists to make precise changes to genomes with relative ease — to correct a disease-causing mutation in dozens of viable human embryos. The study represents a significant improvement in efficiency and accuracy over previous efforts.

This entry was posted in Genetics, Health Regulation & Law and tagged , . Bookmark the permalink.